LYDERM DIN 00716863
Status: Marketed
Holder: TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
Molecule: FLUOCINONIDE
Available to quote
Health Canada record
| Active ingredient(s) | FLUOCINONIDE 0.05 % |
|---|---|
| Dosage form | Cream |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AC08 FLUOCINONIDE |
| Original market date | 31-Dec-1988 |
| Current status date | 06-Dec-2023 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUOCINONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02236996 | LYDERM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Ointment | FLUOCINONIDE 0.05 % | Marketed |
| 02236997 | LYDERM | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Gel | FLUOCINONIDE 0.05 % | Marketed |
| 00598933 | TIAMOL CREAM 0.05% | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. | Cream | FLUOCINONIDE 0.05 % | Marketed |
| 00492442 | LIDECOMB CREAM | MEDICIS CANADA LTD. | Cream | FLUOCINONIDE 0.5 MG; NEOMYCIN SULFATE 5 MG; GRAMICIDIN 0.25 MG; NYSTATIN 100000 UNIT | Cancelled Post Market |
| 02163152 | LIDEMOL | BAUSCH HEALTH, CANADA INC. | Cream | FLUOCINONIDE 0.05 % | Dormant |
| 02161923 | LIDEX | BAUSCH HEALTH, CANADA INC. | Cream | FLUOCINONIDE 0.05 % | Dormant |
| 02161966 | LIDEX | BAUSCH HEALTH, CANADA INC. | Ointment | FLUOCINONIDE 0.05 % | Dormant |
| 02161974 | LIDEX | BAUSCH HEALTH, CANADA INC. | Gel | FLUOCINONIDE 0.05 % | Dormant |
| 00274453 | LIDEX CREAM MILD 0.01% | MEDICIS CANADA LTD. | Cream | FLUOCINONIDE 0.01 % | Cancelled Post Market |
| 00274445 | LIDEX OINTMENT MILD 0.01% | MEDICIS CANADA LTD. | Ointment | FLUOCINONIDE 0.01 % | Cancelled Post Market |
| 00816132 | TOPACTIN CREAM 0.05% U.S.P. | PALADIN PHARMA INC. | Cream | FLUOCINONIDE 0.05 % | Cancelled Post Market |
| 02240269 | TOPACTIN EMOLLIENT CREAM 0.05% | PALADIN PHARMA INC. | Cream | FLUOCINONIDE 0.05 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32282 | 2023-12-06 | Supplement to a New Drug Submission (SNDS) | Update to the Product Monograph. Update to Labels to align with Plain Language Labelling (PLL) regulations. Product Name Change |
| 745 | 2003-09-04 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2280 | 2001-01-31 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for FLUOCINONIDE
5 active FDA Drug Master Files.
Request a quote for LYDERM